Session Two of Defeat Duchenne Canadian Conference Addressing Standards of Care in Canada this Weekend
September 7th is World Duchenne Awareness Day. Over the past decades, life expectancy of individuals affected by Duchenne muscular dystrophy (DMD) has increased significantly, and adults with DMD are not an exception anymore. Adult life with DMD comes with new challenges and opportunities as well as with new medical issues. This World Duchenne Awareness Day, organizations are globally advocating to create opportunities for young adults and adults with DMD to live their lives to the fullest. Read more about today’s global event here.
The NMD4C is proud to partner with Jesse’s Journey and Muscular Dystrophy Canada (MDC) in hosting the first national summit solely focused on DMD for health care providers across Canada, with the theme for this year’s event being ‘Addressing DMD Standards of Care in Canada.’
There’s still time to register for the second session of the CPD-accredited Defeat Duchenne Canadian Conference, coming up this weekend!
Register for session two here
The objectives of this session are to:
- Describe the current standard of Duchenne neuromuscular management and transition from pediatric to adult care in Canada
- Identify and address current gaps in neuromuscular management and transition from pediatric to adult care within their clinics
- Describe the lived experience of neuromuscular management and transition from pediatric to adult clinical care for Duchenne patients and their families
The second session will take place on:
Friday, September 10 from 11 a.m. to 2 p.m. EDT: Neuromuscular Management
Moderated by: Dr. Kathryn Selby (Pediatric Neurologist) and Dr. Hanns Lochmüller (Adult Neurologist)
Agenda:
- DMD care considerations – Dr. Kathryn Selby (Pediatric Neurologist)
- Newborn screening – Dr. Jim Dowling (Pediatric Neurologist)
- Access to medications – Dr. Craig Campbell (Pediatric Neurologist)
- Pediatric/Adult DMD clinics – Dr. Kerri Schellenberg (Adult Neurologist) and Dr. Mike Berger (Adult Physiatrist)
- Education in DMD – Dr. Hanns Lochmüller (Adult Neurologist)
- Steroid management – Dr. Hugh McMillan (Pediatric Neurologist)
- Vamorolone – Dr. Eric Hoffman (Researcher, CEO of ReveraGen)
- Exon skipping – Dr. Craig Campbell (Pediatric Neurologist)
- How to discuss research with families – Dr. Jim Dowling
- Importance of Nutrition – Alex Printis (Dietitian)
- Future directions – Dr. Kathryn Selby (Pediatric Neurologist) and Dr. Hanns Lochmüller (Adult Neurologist)
Other panelists:
- Dr. Suzanne Salsman (Adult Physiatrist)
- Dr. Nadim Jiwa (Adult Neurologist)
Saturday, September 11 from 11 a.m. to 2 p.m. EDT: Transition from Pediatric to Adult Care
Moderated by: Dr. Laura McAdam (Pediatrician) and Dr. Colleen O’Connell (Adult Physiatrist)
Agenda:
- Importance of transition to adult care – Dr. Colleen O’Connell (Adult Physiatrist)
- CPS guidelines on transition of care – Dr. Laura McAdam (Pediatrician)
- Transition to adult care services- Dr. Kathryn Selby (Pediatric Neurologist) and Dr. Hana Alazem (Pediatric/Adult Physiatrist)
- Interactive breakout session 1: How to address current gaps in transition of services
- Transition to adulthood – Bhavnita Mistry (Research Manager/Coordinator), Dr. Monique Taillon (Pediatric Physiatrist), Dr. Laura McAdam (Pediatrician)
- Interactive breakout session 2: How to address current gaps in transition to adulthood.
- Transition resources – Dr. Laura McAdam (Pediatrician)
Other panelists:
- Dr. Sandrine Boueilh (Pediatric Physiatrist)
- Dr. Lindsay Hubenig (Pediatric/Adult Physiatrist)
- Debra Chiabai (Parent)
- Nancy Klinkhamer (Parent)
- Mike Klinkhamer (Adult with Becker muscular dystrophy)
Thank you to everyone from our community who completed the pre-event Canadian Duchenne standards of care survey. The results from the survey will be used as a springboard for discussion during the event and prepared for publication thereafter. We hope to see you at the conference!
The conference is an Accredited Group Learning Activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by The University of Ottawa’s Office of Continuing Professional Development.
Read next...
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.
NMD4C Launches Clinical Summer School
We are excited to announce our inaugural Clinical Summer School, happening in Ottawa, Ontario on September 10–11, 2025. The event will feature hands-on workshops designed to complement the NMD4C Royal College–accredited National Neuromuscular Lecture Series and foster engagement among fellows.
New BIND Study Highlights Financial Burden of Neuromuscular Disorders
Celebrating the Publication of the BIND Study.
We are delighted to share that the BIND study, “Financial Toxicity and Its Determinants in Individuals Living With Neuromuscular Diseases,” has been published in Neurology (2025). This is the first of its kind in Canada to document the true costs of living with neuromuscular diseases
National Training Standards Approved for AFC in Neuromuscular Medicine
We’re pleased to announce that the Royal College of Physicians and Surgeons of Canada has granted final approval for the National Training Standards for the Area of Focused Competence (AFC) in Neuromuscular Medicine!
Expanding National Clinical Outcome Assessment Capacity with Train(e)d
NMD4C and MDC have launched Train(e)d. This initiative is part of NMD4C’s broader efforts to build national capacity in outcome measures and natural history research in support of consistent and high-quality clinical assessments across Canada.
Announcing the 2025 Collaborative Research Training Award Recipients!!!
We are excited to announce the recipients of the 2025 NMD4C Collaborative Research Training Awards which supports Canadian trainees in their efforts to advance neuromuscular disease research while strengthening national collaboration among neuromuscular research laboratories.